The known burden of Huntington disease in the north of Scotland : prevalence of manifest and identified pre-symptomatic gene expansion carriers in the molecular era

Kounidas, GeorgiosCruickshank, HeatherKastora, StavroulaSihlabela, StellaMiedzybrodzka, Zosia2021-10-122021-10-122021-11Kounidas, G, Cruickshank, H, Kastora, S, Sihlabela, S & Miedzybrodzka, Z 2021, 'The known burden of Huntington disease in the north of Scotland : prevalence of manifest and identified pre-symptomatic gene expansion carriers in the molecular era', Journal of Neurology, vol. 268, pp. 4170-4177. https://doi.org/10.1007/s00415-021-10505-w0340-5354Jisc: c8a920a3cf33429c82e8f8522cfd7b5eORCID: /0000-0003-2890-8136/work/175113441https://hdl.handle.net/2164/17346Open access via Springer agreement Acknowledgements: The authors wish to thank Mr Mark Davidson for facilitating data acquisition, and Mr Chris Morrice for commenting on data governance aspects of the manuscript. Funding: The project was in part funded by NHS Grampian Huntington Disease Research Endowment Fund and Medical Research Scotland.81267572engHuntington diseasePrevalenceScotlandGeneral practiceR Medicine (General)R1The known burden of Huntington disease in the north of Scotland : prevalence of manifest and identified pre-symptomatic gene expansion carriers in the molecular eraJournal article10.1007/s00415-021-10505-w268